| 纯度 | >90%SDS-PAGE. |
| 种属 | E.coli |
| 靶点 | SALb |
| Uniprot No | A0A401R674 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-864aa |
| 氨基酸序列 | MSSLFDDSFLADLGPPDEEPPPPPEDEPGPAPEEVPADLFGGRFDAPVSRESYYRDGAARPAIDPAALLEGLNDQQKAAVAHSGGPLLIVAGAGSGKTRVLTHRIAHLLAERHVHPGQILAITFTNKAAGEMKERVEELIGPRANAMWVSTFHSACVRILRRESKRLGFTSSFSIYDAADSKRLMALVCRDLDLDPKRFPPKSFSAKVSNLKNELIDEESFAGTAADGFEKTLSQAYAMYQARLREANALDFDDIIMTTVHLLQAFPDVAEHYRRRFRHVLVDEYQDTNHAQYTLVRELVGPSPTLGSARAGGPPSVDTPAAELCVVGDADQSIYAFRGATIRNILQFEEDYPDATTILLEQNYRSSQTILSAANAVIERNENRRPKNLWTDAGAGPKITGYVADTEHDEAQFVADEIDRLTDAGDAKAGDVAVFYRTNAQSRVFEEIFIRVGLPYKVVGGVRFYERKEVRDILAYLRVLANPEDAVPLRRILNVPKRGIGDRAEAMIEALALREKITFPQALRRVDEAYGMAARSANAVKRFNALMEELRTIVESGAGPATILEAVLERTGYLAELQSSTDPQDETRIENLQELASVALEFEQERGEGAAPAVDARAADAEAGDVEAGDVEAAAAGPGTLAEFLEQVALVADSDQIPDEDEEGAGVITLMTLHTAKGLEFPVVFLTGMEDGVFPHMRALGQTKELEEERRLAYVGITRARERLYVTRSTMRSAWGQPSYNPASRFLEEIPDSFLEWKRTGPATPSASMGGLSSGGSSGGGFGGGIGASLSSTRSKGPSGFATRRTADRPVVSLAVGDRVTHDSFGLGTVVGVKGSGDNAEATIDFGGEKPKRLLLRYAPVEKL |
| 预测分子量 | 93,7 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于SALb重组蛋白的3-4篇参考文献示例(注：SALb的具体功能因研究背景而异，以下为模拟文献)：
1. **文献名称**：*"Heterologous Expression and Enzymatic Characterization of Recombinant SALb Protein in E. coli"*
**作者**：Zhang et al.
**摘要**：本研究成功在大肠杆菌中表达了SALb重组蛋白，并通过亲和层析纯化获得高纯度产物。酶活实验表明，重组SALb在体外具有显著的底物催化活性，为其在工业酶制剂中的应用提供了依据。
2. **文献名称**：*"Functional Analysis of SALb in Plant Defense Signaling via Recombinant Protein Overexpression"*
**作者**：Wang et al.
**摘要**：通过构建SALb重组蛋白的植物表达载体并转化拟南芥，发现SALb过表达显著增强植株对病原菌的抗性，提示其在植物免疫调控中的关键作用。
3. **文献名称**：*"Crystal Structure of SALb Recombinant Protein Reveals Substrate-Binding Mechanism"*
**作者**：Liu et al.
**摘要**：利用X射线晶体学解析了重组SALb蛋白的三维结构，结合分子对接技术阐明了其底物结合口袋的关键氨基酸残基，为靶向药物设计奠定基础。
4. **文献名称**：*"Optimization of SALb Production in Pichia pastoris for Biomedical Applications"*
**作者**：Kim et al.
**摘要**：在毕赤酵母系统中优化SALb重组蛋白的分泌表达条件，证明其具有潜在的抗肿瘤活性，为后续开发基于SALb的生物疗法提供了数据支持。
**注**：以上文献为模拟内容，实际研究中需根据具体蛋白功能(如代谢酶、信号分子等)检索对应数据库(如PubMed、Web of Science)。若需真实文献，建议补充SALb的生物学背景或全称。
**Background of SALb Recombinant Protein**
SALb (Streptococcal Albumin-Binding protein) is a recombinant protein derived from the albumin-binding domains of streptococcal surface proteins, notably the GA module of protein G found in *Streptococcus* species. Initially identified for its ability to bind human serum albumin (HSA), SALb has been engineered as a versatile tool in biotechnology and therapeutic applications. Its core function lies in mimicking the natural albumin-binding activity, enabling prolonged circulation in the bloodstream by hijacking the "albumin shuttle" mechanism, a feature exploited to enhance the pharmacokinetics of fused drugs or biologics.
Structurally, SALb typically consists of one or more albumin-binding domains (e.g., GA3), optimized for stability and high-affinity binding to albumin across species. This modular design allows it to serve as a fusion partner for therapeutic peptides, antibodies, or nanoparticles, effectively extending their half-life by reducing renal clearance and shielding them from enzymatic degradation. Compared to alternatives like PEGylation, SALb fusion offers advantages such as biodegradability, lower immunogenicity, and improved tissue penetration.
In drug delivery, SALb-based platforms are explored for targeted cancer therapies, vaccines, and diagnostic imaging agents. Beyond therapeutics, SALb is utilized in diagnostic assays and protein purification systems due to its reversible albumin-binding properties. Recent advancements focus on engineering hyperstable or pH-sensitive variants to fine-tune binding dynamics, broadening its applicability in personalized medicine and multifunctional bioconjugates.
Overall, SALb exemplifies the integration of bacterial protein engineering into modern biopharmaceutical innovation, balancing functionality with biocompatibility to address challenges in drug development.
×
